Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 8, 2010, Pages 3782-3787

  Schlecht Louf, Géraldine ^a,b   Renard, Martial ^a   Mangeney, Marianne ^a   Letzelter, Claire ^a   Richaud, Aurélien ^a   Ducos, Bertrand ^a   Bouallaga, Isabelle ^a   Heidmann, Thierry ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Adaptive immunity; Immunosuppression; Infectious retrovirus; Innate immunity; Vaccination

Indexed keywords

ENVELOPE PROTEIN; VIRULENCE FACTOR; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; EFFECTOR CELL; EX VIVO STUDY; FRIEND LEUKEMIA VIRUS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INNATE IMMUNITY; IRRADIATION; KINETICS; MOUSE; MUTANT; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RETROVIRUS INFECTION; VIRION; VIRUS INFECTION; VIRUS INFECTIVITY;

ANIMALS; FRIEND MURINE LEUKEMIA VIRUS; IMMUNE TOLERANCE; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUTATION; NIH 3T3 CELLS; RETROVIRIDAE INFECTIONS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR VIRUS INFECTIONS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRULENCE FACTORS;

FRIEND MURINE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MURINAE; MUS; PRIMATES;

EID: 77649267384     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0913122107     Document Type: Article

References (33)

1. Bowie AG, Unterholzner L (2008) Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8:911-922.
2. Hansen TH, Bouvier M (2009) MHC class I antigen presentation: Learning from viral evasion strategies. Nat Rev Immunol 9:503-513.
3. Jonjić S, Babić M, Polić B, Krmpotić A (2008) Immune evasion of natural killer cells by viruses. Curr Opin Immunol 20:30-38.
4. Malim MH, Emerman M (2008) HIV-1 accessory proteins - Ensuring viral survival in a hostile environment. Cell Host Microbe 3:388-398.
5. Iannello A, et al. (2006) Viral strategies for evading antiviral cellular immune responses of the host. J Leukocyte Biol 79:16-35.
6. Schneider-Schaulies S, Dittmer U (2006) Silencing T cells or T-cell silencing: Concepts in virus-induced immunosuppression. J Gen Virol 87:1423-1438.
7. Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R (1985) Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230:453-455.
8. Blaise S, Mangeney M, Heidmann T (2001) The envelope of Mason-Pfizer monkey virus has immunosuppressive properties. J Gen Virol 82:1597-1600.
9. Mangeney M, Heidmann T (1998) Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc Natl Acad Sci USA 95:14920-14925.
10. Mangeney M, et al. (2007) Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci USA 104:20534-20539.
11. Sitbon M, et al. (1990) Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses. J Virol 64: 2135-2140.
12. Renard M, et al. (2005) Crystal structure of a pivotal domain of human syncytin-2, a 40 million years old endogenous retrovirus fusogenic envelope gene captured by primates. J Mol Biol 352:1029-1034.
13. Urisman A, et al. (2006) Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2:e25.
14. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A (2002) A thymic precursor to the NK T cell lineage. Science 296:553-555.
15. Letvin NL, et al. (2007) No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys. J Virol 81:12368-12374.
16. Mansfield K, et al. (2008) Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and highfrequency cellular immune responses measurable in the periphery. J Virol 82: 4135-4148.
17. Chen W, Qin H, Chesebro B, Cheever MA (1996) Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors. J Virol 70:7773-7782.
18. Iwashiro M, et al. (1993) Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells. J Virol 67:4533-4542.
19. Rouse BT, Sarangi PP, Suvas S (2006) Regulatory T cells in virus infections. Immunol Rev 212:272-286.
20. Ralainirina N, et al. (2007) Control of NK cell functions by CD4+CD25+ regulatory T cells. J Leukocyte Biol 81:144-153.
21. Robertson SJ, Messer RJ, Carmody AB, Hasenkrug KJ (2006) In vitro suppression of CD8+ T cell function by Friend virus-induced regulatory T cells. J Immunol 176: 3342-3349.
22. Dittmer U, et al. (2004) Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 20:293-303.
23. Iwashiro M, et al. (2001) Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc Natl Acad Sci USA 98:9226-9230.
24. Myers L, Messer RJ, Carmody AB, Hasenkrug KJ (2009) Tissue-specific abundance of regulatory T cells correlates with CD8+ T cell dysfunction and chronic retrovirus loads. J Immunol 183:1636-1643.
25. Zelinskyy G, et al. (2005) CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection. J Virol 79:10619-10626.
26. Zelinskyy G, Kraft AR, Schimmer S, Arndt T, Dittmer U (2006) Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection. Eur J Immunol 36:2658-2670.
27. Zelinskyy G, et al. (2009) The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virusspecific cytotoxic T-cell response. Blood 114:3199-3207.
28. He H, et al. (2004) Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection. J Virol 78:11641-11647.
29. Andrews DM, et al. (2005) Cross-talk between dendritic cells and natural killer cells in viral infection. Mol Immunol 42:547-555.
30. Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621-667.
31. Suzuki T, et al. (1995) Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J Exp Med 182:477-486.
32. Blaise S, de Parseval N, Bénit L, Heidmann T (2003) Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc Natl Acad Sci USA 100:13013-13018.
33. Blaise S, Ruggieri A, Dewannieux M, Cosset FL, Heidmann T (2004) Identification of an envelope protein from the FRD family of human endogenous retroviruses (HERV-FRD) conferring infectivity and functional conservation among simians. J Virol 78: 1050-1054.